CD8A and neoplasm: Our results therefore suggest that IL-2WTFc administration contributes to the establishment of a highly immunogenic tumour microenvironment that favours the infiltration of immune cells in general, and of CD8+ T-cells in particular, leading to enhanced antitumour responses.